Sensus Healthcare, Inc. (NASDAQ:SRTS – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $2.97 and traded as low as $2.86. Sensus Healthcare shares last traded at $3.23, with a volume of 103,027 shares changing hands.
Wall Street Analyst Weigh In
SRTS has been the subject of a number of research reports. Wall Street Zen cut shares of Sensus Healthcare from a “sell” rating to a “strong sell” rating in a research report on Saturday, May 9th. Lake Street Capital dropped their price objective on Sensus Healthcare from $4.50 to $4.00 and set a “buy” rating on the stock in a report on Friday, August 14th. Weiss Ratings cut Sensus Healthcare from a “sell (d)” rating to a “sell (d-)” rating in a research report on Tuesday. Alliance Global Partners reissued a “buy” rating on shares of Sensus Healthcare in a report on Monday. Finally, Citigroup reissued a “buy” rating on shares of Sensus Healthcare in a research report on Friday, May 8th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Sensus Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $5.83.
Check Out Our Latest Stock Report on SRTS
Sensus Healthcare Trading Up 7.3%
Sensus Healthcare (NASDAQ:SRTS – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.41). The business had revenue of $2.29 million for the quarter, compared to analysts’ expectations of $4.60 million. Sensus Healthcare had a negative return on equity of 21.57% and a negative net margin of 88.45%.
Institutional Investors Weigh In On Sensus Healthcare
Several hedge funds have recently made changes to their positions in SRTS. Geode Capital Management LLC increased its position in Sensus Healthcare by 2.5% in the 2nd quarter. Geode Capital Management LLC now owns 153,917 shares of the company’s stock valued at $730,000 after acquiring an additional 3,766 shares during the period. Sachetta LLC lifted its position in Sensus Healthcare by 6.8% during the 4th quarter. Sachetta LLC now owns 148,508 shares of the company’s stock worth $591,000 after acquiring an additional 9,500 shares during the period. Pacific Ridge Capital Partners LLC lifted its position in Sensus Healthcare by 21.8% during the 4th quarter. Pacific Ridge Capital Partners LLC now owns 698,634 shares of the company’s stock worth $2,781,000 after acquiring an additional 125,245 shares during the period. Jane Street Group LLC purchased a new position in shares of Sensus Healthcare in the 4th quarter valued at approximately $79,000. Finally, State Street Corp grew its stake in shares of Sensus Healthcare by 5.2% in the 4th quarter. State Street Corp now owns 69,252 shares of the company’s stock valued at $276,000 after purchasing an additional 3,400 shares during the last quarter. Institutional investors and hedge funds own 25.30% of the company’s stock.
About Sensus Healthcare
Sensus Healthcare, Inc is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company’s SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare’s systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients.
The company’s flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls.
See Also
- Five stocks we like better than Sensus Healthcare
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Sensus Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
